MedPath

The effect of Repetitive transcranial magnetic stimulation (r-TMS) in the Dorsolateral Prefrontal Cortex (DLPFC) on the symptoms of patients with obsessive-compulsive disorder

Phase 3
Recruiting
Conditions
Obsessive-compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20230508058128N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Definitive diagnosis of OCD based on the DSM V diagnostic criteria by two psychiatrists (clinical interview)
obtaining a score equal to or greater than 16 from the Y-BOCS questionnaire,
not taking related drugs in the last four weeks and starting drug treatment with sertraline 150 mg (simultaneously to along with r-TMS for the intervention group),
not receiving ECT in the past 6 months and the willingness of the subjects to participate in the research

Exclusion Criteria

Existence of accompanying psychiatric disorder, especially depression (based on Beck Depression Scale) score of Beck Questionnaire above 10, suffering from seizures
use of drugs and substances, presence of metal implants, pacemaker, trauma or head injury and neurosurgery procedures
incompleteness of patients data more than 10%

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Yale-Brown Obsession Scale. Timepoint: Before the start of the study, after each RTMS session, 3 months after the last session. Method of measurement: Using a standard questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of Life Brief Version (WHOQOL-BREF). Timepoint: Before the intervention, after each session, 3 months after the last session. Method of measurement: Based on a standard questionnaire.;Symptoms of obsession. Timepoint: Before the intervention, after each session, 3 months after the last session. Method of measurement: Based on a standard questionnaire.;Beck depression questionnaire 2. Timepoint: Before the intervention, after each session, 3 months after the last session. Method of measurement: Based on a standard questionnaire.
© Copyright 2025. All Rights Reserved by MedPath